| Financial Year |
March 31 2023 |
| Monetary Funds |
7,248,490,938.80 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
5,000,000.00 |
| Accounts Receivable |
50,873,547,104.09 |
| Advances to Suppliers |
1,041,784,026.34 |
| Other Receivables |
29,313,926,463.14 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
267,411,365.33 |
| Dividend Receivable |
-- |
| Inventories |
99,510,565,577.23 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
3,662,449,289.23 |
| Other Current Assets |
10,036,605,539.40 |
| Total Current Assets |
337,663,997,942.45 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
5,619,434,500.10 |
| Long-term Equity Investment |
5,994,166,234.54 |
| Investment Properties |
2,598,764,421.53 |
| Fixed Assetes |
8,099,538,392.80 |
| Under-construction Projects |
3,658,900,172.98 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
4,806,516,013.25 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,546,561,648.81 |
| Deferred Income Tax Assets |
12,865,924,078.09 |
| Other Non-Current Assets |
10,660,000.00 |
| Sub-Total of Non-Current Assets |
46,440,421,512.60 |
| Total Assets |
384,104,419,455.05 |
| Short-Term Loans |
9,723,862,069.85 |
| Trading Financial liabilities |
-- |
| Notes Payable |
141,164,054.59 |
| Accounts Payable |
45,494,892,881.63 |
| Accounts Received In Advance |
140,293,957.45 |
| Employee Compensation Payable |
228,399,072.78 |
| Taxes Payable |
10,526,222,822.63 |
| Interest Payable |
6,321,879,759.53 |
| Dividend Payable |
-- |
| Other payables |
24,194,542,245.36 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
26,736,431,127.20 |
| Other Current Liabilities |
12,704,797,989.25 |
| Sub-Total of Current Liabilities |
189,066,531,982.78 |
| Long-term Loans |
95,733,303,758.39 |
| Bonds Payable |
60,852,337,292.96 |
| Long-Term Accounts Payable |
1,460,260,925.59 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,358,938,398.03 |
| Other Non-Current Liabilities |
8,230,843,475.33 |
| Sub-Total of Non-Current Liabilities |
168,709,038,655.21 |
| Total Liabilities |
357,775,570,637.99 |
| Paid-In Capital(Or Share Stock) |
3,893,355,062.00 |
| Capital Surplus |
5,064,294,799.45 |
| Surplus Reserve |
1,516,920,436.76 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,129,212,801.00 |
| Minority Stockholder's Interest |
15,183,342,229.33 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
11,145,506,587.73 |
| Owner's Equity（Stockholder's Equity） |
26,328,848,817.06 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
384,104,419,455.05 |
